In Recent Guidance, FDA aims for Patient Safety at 503B Facilities
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
Take Control of Patient Safety and Quality Control with InsightRX
Just last week, ConsortiEX proudly announced our new InsightRX Passive Audit Monitoring module.
FDA Commissioner Details Steps to Ensure the Quality of and Preserve Access to Compounded Drugs
The practice of compounding medicines can provide important public health opportunities. The FDA’s compounding program – including implementation of the compounding provisions of the law – is a priority for the agency. We recognize that in delivering on implementation commitments, we must balance the need to preserve[...]
Thanks for stopping by the ConsortiEX booth to discover the power of our Pharmacy-Focused ERP.
We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.
ConsortiEX CEO Neal Long Talks Patient Safety
We recently sat down with ConsortiEX CEO, Neal Long, to discuss the company’s background and learn more about its plans to help hospitals safely distribute, source and track compounded pharmaceuticals among affiliated hospitals. addresses the worldwide problem of drug availability, patient safety and high costs. The[...]